Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00404066
Brief Title: Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer

First Submitted : November 22, 2006
First Submitted that Met QC Criteria : November 22, 2006
First Posted : November 27, 2006 (Estimate)

Results First Submitted : February 3, 2017
Results First Submitted that Met QC Criteria : November 28, 2017
Results First Posted : December 22, 2017

Last Update Submitted that Met QC Criteria : November 28, 2017
Last Update Posted : December 22, 2017